Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial
Top Cited Papers
- 1 August 2003
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 362 (9383), 516-522
- https://doi.org/10.1016/s0140-6736(03)14110-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Prolonged Single-Agent Versus Combination Chemotherapy in Indolent Follicular Lymphomas: A Study of the Cancer and Leukemia Group BJournal of Clinical Oncology, 2003
- Intensive therapies in follicular non-Hodgkin lymphomasBlood, 2002
- Immunochemotherapy in indolent non-Hodgkin's lymphomaSeminars in Oncology, 2002
- Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortalityBlood, 2001
- Follicular lymphoma: Have we made any progress?Annals of Oncology, 2000
- Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas: A randomized trial from the Lymphoma Group of Central SwedenAnnals of Oncology, 1994
- SPONTANEOUS REMISSION IN CHRONIC LYMPHOCYTIC LEUKAEMIABritish Journal of Haematology, 1988
- The Natural History of Initially Untreated Low-Grade Non-Hodgkin's LymphomasThe New England Journal of Medicine, 1984
- No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic TypesAnnals of Internal Medicine, 1979
- CLASSIFICATION OF NON-HODGKIN'S LYMPHOMASThe Lancet, 1974